| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Zoology, The University of Hong Kong (R.T.-K.P., S.S.-M.N., B.K.-C.C.), and the Department of Biochemistry, Chinese University of Hong Kong (C.H.-K.C.), Hong Kong, Special Administrative Region, Peoples Republic of China; and the Center for Basic Research in Digestive Diseases, Mayo Clinic and Foundation (M.H.H., L.J.M.), Rochester, Minnesota 55905
Address all correspondence and requests for reprints to: Dr. B. K. C. Chow, Department of Zoology, University of Hong Kong, Pokfulam Road, Hong Kong, Special Administrative Region, Peoples Republic of China. E-mail: bkcc{at}hkusua.hku.hk
Secretin is a 27-amino acid long peptide hormone that regulates pancreatic water, bicarbonate, enzymes, and potassium ion secretion. The human secretin receptor (hSR) is a glycoprotein consisting of 440 amino acids, of which there are 5 putative N-linked glycosylation sites at positions Asn72, Asn100, Asn106, Asn128 (N-terminal ectodomain), and Asn291 (second exoloop). Through functional analysis of the hSR-transfected cells cultured in the presence of various glycosylation inhibitors, it was found that tunicamycin and castanospermine were able to significantly reduce the secretin-stimulated cAMP response. On the other hand, the effects of other inhibitors, swainsonine and deoxymannojirimycin, were much lower, suggesting that the high mannose-type carbohydrate side-chain is essential to the expression of a fully functional hSR. The role of individual N-linked glycosylation sites was studied by mutation analysis (Asn to Leu or Ser to Ala) coupled to measurements of cAMP accumulation and extracellular acidification rate. The ED50 values of the wild-type receptor in these two assay systems were 0.25 and 0.11 nM, respectively, and mutation at position 100, 106, or 291 did not affect either the ED50 values or the maximal responses in the two assays. However, the Asn72Leu and Ser74Ala mutations reduced the maximal responses and increased the ED50 values in both assays, suggesting that this site is a true glycosylation signal. This hypothesis was further supported by competitive binding studies, the same mutants were found to be defective in binding with [125I]secretin. To evaluate whether the change in receptor function of the mutants is caused by the change in the process of presenting the receptor to the cell surface, the mutants and the wild-type receptor were tagged with a c-Myc epitope at the C-termini. Using an anti-c-Myc monoclonal antibody and confocal microscopy, all of the mutant receptors were found to be expressed and delivered to the plasma membrane.
This article has been cited by other articles:
![]() |
M Hellstrand, E A Danielsen, V M Steen, A Ekman, E Eriksson, and C L Nilsson The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells J. Med. Genet., November 1, 2004; 41(11): 867 - 871. [Full Text] [PDF] |
||||
![]() |
B. K. C. Chow, T. W. Moon, R. L. C. Hoo, C.-M. Yeung, M. Muller, P. J. Christos, and S. Mojsov Identification and Characterization of a Glucagon Receptor from the Goldfish Carassius auratus: Implications for the Evolution of the Ligand Specificity of Glucagon Receptors in Vertebrates Endocrinology, July 1, 2004; 145(7): 3273 - 3288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dong, M. Zang, D. I. Pinon, Z. Li, T. P. Lybrand, and L. J. Miller Interaction among Four Residues Distributed through the Secretin Pharmacophore and a Focused Region of the Secretin Receptor Amino Terminus Mol. Endocrinol., November 1, 2002; 16(11): 2490 - 2501. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Q. Ding, Z.-J. Cheng, J. McElhiney, S. M. Kuntz, and L. J. Miller Silencing of Secretin Receptor Function by Dimerization with a Misspliced Variant Secretin Receptor in Ductal Pancreatic Adenocarcinoma Cancer Res., September 15, 2002; 62(18): 5223 - 5229. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Q. Assil and A. B. Abou-Samra N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E1015 - E1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y.-Y. Chan, R. T.-K. Pang, and B. K.-C. Chow Functional Segregation of the Highly Conserved Basic Motifs within the Third Endoloop of the Human Secretin Receptor Endocrinology, September 1, 2001; 142(9): 3926 - 3934. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, S. C. Austin, and E. M. Smyth Glycosylation of the Human Prostacyclin Receptor: Role in Ligand Binding and Signal Transduction Mol. Pharmacol., September 1, 2001; 60(3): 480 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Solomon, G. Varga, N. Zeng, S. V. Wu, J. H. Walsh, and J. R. Reeve Jr. Different actions of secretin and Gly-extended secretin predict secretin receptor subtypes Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G88 - G94. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagayama, E. Nishihara, H. Namba, S. Yamashita, and M. Niwa Identification of the Sites of Asparagine-Linked Glycosylation on the Human Thyrotropin Receptor and Studies on Their Role in Receptor Function and Expression J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 404 - 409. [Abstract] [Full Text] |
||||
![]() |
M. Dong, Y. W. Asmann, M. Zang, D. I. Pinon, and L. J. Miller Identification of Two Pairs of Spatially Approximated Residues within the Carboxyl Terminus of Secretin and Its Receptor J. Biol. Chem., August 18, 2000; 275(34): 26032 - 26039. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Ding, V. Dolu, E. M. Hadac, E. L. Holicky, D. I. Pinon, T. P. Lybrand, and L. J. Miller Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe J. Biol. Chem., February 2, 2001; 276(6): 4236 - 4244. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |